1. Home
  2. Live Updates
  3. European society for medical oncology congress

Live Breaking News & Updates on European society for medical oncology congress

Stay informed with the latest breaking news from European society for medical oncology congress on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in European society for medical oncology congress and stay connected to the pulse of your community

Johnson & Johnson receives positive CHMP opinion for

This positive CHMP opinion establishes amivantamab as a new option, and the first fully-human EGFR-MET bispecific antibody, in the first-line treatment of...

Singapore , Belgium , Saclay , France-general- , France , Beerse , Region-flamande , United-states , American , Nicolas-girard , Henar-hevia , Institut-curie

HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda

HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Japan , United-states , China , Iceland , Macau , Panmure , Victoria , Australia , Hong-kong , Cairo , Al-qahirah , Egypt

Positive CHMP Opinion for Fruquintinib | Company Announcement

Investegate announcements from Positive CHMP Opinion for Fruquintinib

Australia , China , Japan , Panmure , Victoria , United-states , Liechtenstein , Hong-kong , Norway , Iceland , Macau , American

Phase 3 Trial Launches for Keytruda, MK-1084 in KRAS-Mutant NSCLC

A clinical trial has started to evaluate the investigational drug MK-1084 and Keytruda among some patients with metastatic non-small cell lung cancer.

Merck-research-laboratories , European-society-for-medical-oncology-congress , National-cancer-institute , Marjorie-green , Mutant-lung-cancer , European-society , Medical-oncology-congress , News , Lung-cancer , Nsclc , Kras-mutant-nsclc

REJOICE-Ovarian01 Phase 2/3 Trial of Raludotatug Deruxtecan Initiated in Patients with Platinum-Resistant Ovarian Cancer

Daiichi Sankyo and Merck , known as MSD outside of the United States and Canada, announced today that the first patient has been dosed in the REJOICE-Ovarian01 phase 2/3 trial evaluating the...

Canada , Japan , Colombo , Western , Sri-lanka , United-states , America , Daiichi-sankyo , Raludotatug-deruxtecan , Mark-rutstein , European-society-for-medical-oncology-congress , Linkedin

Harpoon Therapeutics : April 3, 2024 -April 03, 2024 at 08:32 am EDT

BASKING RIDGE, N.J. & RAHWAY, N.J., April 3, 2024 - Daiichi Sankyo and Merck , known as MSD outside of the United States and Canada, announced today that the first patient has been...

Japan , Colombo , Western , Sri-lanka , Canada , United-states , America , Koji-ogiwara , Carly-myar , Peter-dannenbaum , Mark-rutstein , Jennifer-brennan

AstraZeneca (AZN) reports Datopotamab deruxtecan BLA accepted in the US

AstraZeneca (AZN) reports Datopotamab deruxtecan BLA accepted in the US
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

China , San-antonio , Texas , United-states , Japan , Susan-galbraith , Ken-takeshita , Daiichi-sankyo , Daiichi-sankyo-biologics , European-society-for-medical-oncology-congress , Drug-administration , Astrazeneca

AstraZeneca and Daiichi Sankyo's BLA for Datopotamab Deruxtecan Accepted by FDA for Advanced Breast Cancer Treatment

AstraZeneca and Daiichi Sankyo's BLA for Datopotamab Deruxtecan Accepted by FDA for Advanced Breast Cancer Treatment
news.europawire.eu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news.europawire.eu Daily Mail and Mail on Sunday newspapers.

United-kingdom , San-antonio , Texas , United-states , Sapporo , Hokkaido , Japan , Canada , Cambridge , Cambridgeshire , China , America

AstraZeneca : Datopotamab deruxtecan Biologics License Application accepted in the US for patients with previously treated metastatic HR-positive, HER2-negative breast cancer - Form 6-K -April 02, 2024 at 07:58 am EDT

a9023i












FORM 6-K


SECURITIES AND EXCHANGE COMMISSION


...

United-kingdom , Cambridge , Cambridgeshire , Japan , United-states , Canada , Washington , San-antonio , Texas , Sapporo , Hokkaido , China

Jacobio Pharma Announces 2023 Annual Results

Jacobio Pharma Announces 2023 Annual Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Boston , Massachusetts , United-states , China , Beijing , Shanghai , American , Jacobio-prnewswire , Wang-yinxiang , Jacobio-pharma , American-society-of-clinical-oncology , European-society-for-medical-oncology-congress